日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nonselective β-Adrenergic Receptor Inhibitors Impair Hematopoietic Regeneration in Mice and Humans after Hematopoietic Cell Transplants

非选择性β-肾上腺素能受体抑制剂会损害小鼠和人类造血细胞移植后的造血再生能力

Jinsuke Nishino # ,Wenhuo Hu # ,Ashwin Kishtagari # ,Bo Shen ,Xiang Gao ,Caroline M Blackman ,Adetola Kassim ,Naimisha Marneni ,Abhisar V Cherukuri ,Russell Vittrup ,Fatma N Kalkan ,Rahul Shah ,Chul Ahn ,Ang Gao ,Abeer Ahmedrabie ,Robert H Collins ,Amer M Zeidan ,Aram Bidikian ,Lohith Gowda ,Brian C Shaffer ,Yazan F Madanat ,Zhiyu Zhao ,Stephen S Chung ,Sean J Morrison

Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant

异基因造血细胞移植前后以维奈克拉为基础的联合治疗 AML 和高危 MDS

Jan Philipp Bewersdorf, Andriy Derkach, Lohith Gowda, Kamal Menghrajani, Susan DeWolf, Josel D Ruiz, Doris M Ponce, Brian C Shaffer, Roni Tamari, James W Young, Ann A Jakubowski, Boglarka Gyurkocza, Alexander Chan, Wenbin Xiao, Jacob Glass, Amber C King, Sheng F Cai, Anthony Daniyan, Christopher Fam

Siglec-6 on Chronic Lymphocytic Leukemia Cells Is a Target for Post-Allogeneic Hematopoietic Stem Cell Transplantation Antibodies

慢性淋巴细胞白血病细胞上的 Siglec-6 是异基因造血干细胞移植后抗体的靶点

Jing Chang, Haiyong Peng, Brian C Shaffer, Sivasubramanian Baskar, Ina C Wecken, Matthew G Cyr, Gustavo J Martinez, Jo Soden, Jim Freeth, Adrian Wiestner, Christoph Rader

KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation

KIR3DL1/HLA-B 亚型调控造血细胞移植后急性髓性白血病复发

Jeanette E Boudreau, Fabio Giglio, Ted A Gooley, Philip A Stevenson, Jean-Benoît Le Luduec, Brian C Shaffer, Raja Rajalingam, Lihua Hou, Carolyn Katovich Hurley, Harriet Noreen, Elaine F Reed, Neng Yu, Cynthia Vierra-Green, Michael Haagenson, Mari Malkki, Effie W Petersdorf, Stephen Spellman, Kathar